- Home
- NVVE vs CHEK Comparison
NVVE vs CHEK Comparison
Compare NVVE & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- CHEK
- Stock Information
- Founded
- NVVE 1996
- CHEK 2004
- Country
- NVVE United States
- CHEK Israel
- Employees
- NVVE N/A
- CHEK N/A
- Industry
- NVVE Oil Refining/Marketing
- CHEK Medical Electronics
- Sector
- NVVE Energy
- CHEK Health Care
- Exchange
- NVVE Nasdaq
- CHEK Nasdaq
- Market Cap
- NVVE 4.2M
- CHEK 3.9M
- IPO Year
- NVVE N/A
- CHEK 2015
- Fundamental
- Price
- NVVE $0.25
- CHEK $0.76
- Analyst Decision
- NVVE
- CHEK
- Analyst Count
- NVVE 0
- CHEK 0
- Target Price
- NVVE N/A
- CHEK N/A
- AVG Volume (30 Days)
- NVVE 5.1M
- CHEK 495.0K
- Earning Date
- NVVE 11-11-2025
- CHEK 11-28-2025
- Dividend Yield
- NVVE N/A
- CHEK N/A
- EPS Growth
- NVVE N/A
- CHEK N/A
- EPS
- NVVE N/A
- CHEK N/A
- Revenue
- NVVE $4,949,747.00
- CHEK N/A
- Revenue This Year
- NVVE $892.33
- CHEK N/A
- Revenue Next Year
- NVVE N/A
- CHEK N/A
- P/E Ratio
- NVVE N/A
- CHEK N/A
- Revenue Growth
- NVVE N/A
- CHEK N/A
- 52 Week Low
- NVVE $0.18
- CHEK $0.56
- 52 Week High
- NVVE $8.76
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- NVVE 29.80
- CHEK 58.60
- Support Level
- NVVE $0.23
- CHEK $0.65
- Resistance Level
- NVVE $0.28
- CHEK $0.80
- Average True Range (ATR)
- NVVE 0.06
- CHEK 0.08
- MACD
- NVVE -0.00
- CHEK 0.01
- Stochastic Oscillator
- NVVE 23.13
- CHEK 31.30
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.